Table 1 Patient characteristics
All | Stroke Recurrence | p | ||
|---|---|---|---|---|
No | Yes | |||
Number of patients | 390 | 355 | 35 | |
Age (years) | 66.7 ± 11.9 | 66.5 ± 11.8 | 69.0 ± 12.7 | 0.239 |
Male sex, n (%) | 219 (56.2%) | 200 (56.3%) | 19 (54.3%) | 0.815 |
Hypertension, n (%) | 273 (70.0%) | 246 (69.3%) | 27 (77.1%) | 0.440 |
Diabetes, n (%) | 107 (27.4%) | 102 (28.7%) | 5 (14.3%) | 0.075 |
Dyslipidemia, n (%) | 160 (41.0%) | 145 (40.8%) | 15 (42.9%) | 0.858 |
Chronic kidney disease, n (%) | 17 (4.4%) | 14 (3.9%) | 3 (8.6%) | 0.383 |
Vascular disease, n (%) | 12 (3.1%) | 10 (2.8%) | 2 (5.7%) | 0.294 |
Coronary artery disease, n (%) | 41 (10.5%) | 37 (10.4%) | 4 (11.4%) | 0.775 |
Cigarette smokers, n (%) | 148 (37.9%) | 130 (36.6%) | 18 (51.4%) | 0.101 |
Echocardiographic parameters | ||||
LA diameter (mm) | 36.4 ± 4.5 | 36.3 ± 4.5 | 37.1 ± 4.7 | 0.353 |
LA volume (mm3) | 41.2 ± 11.8 | 40.8 ± 11.6 | 45.6 ± 13.1 | 0.020 |
LA volume index (mm3/m2) | 24.5 ± 6.9 | 24.2 ± 6.6 | 27.7 ± 9.0 | 0.005 |
LVEF (%) | 66.6 ± 8.8 | 66.7 ± 8.8 | 66.1 ± 8.3 | 0.707 |
LV mass index (g/m2) | 106.1 ± 28.9 | 105.5 ± 27.3 | 111.9 ± 42.6 | 0.231 |
E/e′ | 12.0 ± 4.5 | 11.9 ± 4.4 | 12.9 ± 5.0 | 0.206 |
APCs (n) | 541.0 ± 2565.7 | 528.6 ± 2605.4 | 636.3 ± 2262.9 | 0.791 |
MAPCs | 229 (58.7%) | 202 (56.9%) | 27 (77.1%) | 0.030 |
Medication | ||||
Aspirin, n (%) | 301 (77.2%) | 273 (76.9%) | 28 (80.0%) | 0.834 |
Triflusal, n (%) | 30 (7.7%) | 29 (8.2%) | 1 (2.9%) | 0.501 |
Clopidogrel, n (%) | 203 (52.1%) | 185 (52.1%) | 18 (51.4%) | 1.000 |